AU503212B2 - 1-(3,5-dihydroxyphenyl)-2[hydroxyalkyl)amino] ethanols and their esters - Google Patents
1-(3,5-dihydroxyphenyl)-2[hydroxyalkyl)amino] ethanols and their estersInfo
- Publication number
- AU503212B2 AU503212B2 AU18122/76A AU1812276A AU503212B2 AU 503212 B2 AU503212 B2 AU 503212B2 AU 18122/76 A AU18122/76 A AU 18122/76A AU 1812276 A AU1812276 A AU 1812276A AU 503212 B2 AU503212 B2 AU 503212B2
- Authority
- AU
- Australia
- Prior art keywords
- ethanols
- dihydroxyphenyl
- hydroxyalkyl
- esters
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical class CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title 1
- 150000002148 esters Chemical class 0.000 title 1
- 235000019441 ethanol Nutrition 0.000 title 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 title 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/04—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
- C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7510988A SE7510988L (sv) | 1975-10-01 | 1975-10-01 | Nya farmaceutiskt aktiva foreningar |
| SESE7510988/ | 1975-10-01 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU1812276A AU1812276A (en) | 1978-04-06 |
| AU503212B2 true AU503212B2 (en) | 1979-08-30 |
Family
ID=20325688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU18122/76A Expired AU503212B2 (en) | 1975-10-01 | 1976-09-27 | 1-(3,5-dihydroxyphenyl)-2[hydroxyalkyl)amino] ethanols and their esters |
Country Status (19)
| Country | Link |
|---|---|
| JP (1) | JPS5242840A (https=) |
| AT (1) | AT347427B (https=) |
| AU (1) | AU503212B2 (https=) |
| BE (1) | BE846837A (https=) |
| CS (2) | CS199644B2 (https=) |
| DD (1) | DD126278A5 (https=) |
| DE (1) | DE2640972A1 (https=) |
| DK (1) | DK141622B (https=) |
| ES (1) | ES451979A1 (https=) |
| FI (1) | FI762660A7 (https=) |
| FR (1) | FR2326183A1 (https=) |
| GB (1) | GB1542317A (https=) |
| LU (1) | LU75916A1 (https=) |
| NL (1) | NL7610845A (https=) |
| NO (1) | NO763345L (https=) |
| NZ (1) | NZ182165A (https=) |
| SE (1) | SE7510988L (https=) |
| SU (2) | SU638252A3 (https=) |
| ZA (1) | ZA765331B (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3163871D1 (en) | 1980-07-09 | 1984-07-05 | Draco Ab | 1-(dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates |
| EP0103830A3 (de) * | 1982-09-22 | 1985-07-31 | Bayer Ag | Wachstumsfördernde Phenylethylamin-Derivate |
| ES2230571T3 (es) * | 1995-12-28 | 2005-05-01 | Mitsubishi Pharma Corporation | `composicion farmaceutica destinada para la administracion topica que comprende el 2-amino-2-(2-(4-octilfenil)etil) propan-1,3-diol para el tratamiento de las enfermedades causadas por una alteracion inmunitaria. |
| HUE028976T2 (en) | 2003-06-17 | 2017-02-28 | Arena Pharm Inc | 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride |
| EP2471779A1 (en) | 2006-04-03 | 2012-07-04 | Arena Pharmaceuticals, Inc. | Process for the resolution of a mixture of (R)- and (S)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine |
| US8299241B2 (en) | 2006-12-05 | 2012-10-30 | Arena Pharmaceuticals, Inc. | Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof |
| RU2361604C1 (ru) * | 2007-10-29 | 2009-07-20 | Федеральное агентство по высокотехнологичной медицинской помощи Федеральное государственное учреждение "Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии" (ФГУ УрНИИДВиИ Росмедтехнологий) | Способ лечения атопического дерматита |
| CN102015591B (zh) | 2008-03-04 | 2014-01-29 | 艾尼纳制药公司 | 制备与5-ht2c激动剂(r)-8-氯-1-甲基-2，3，4，5-四氢-1h-3-苯并氮杂卓相关的中间体的方法 |
| US8952197B2 (en) | 2009-06-18 | 2015-02-10 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-HT2C receptor agonists |
| KR20130112848A (ko) | 2010-06-02 | 2013-10-14 | 아레나 파마슈티칼스, 인크. | 5-ｈｔ2ｃ 수용체 아고니스트의 제조 방법 |
| KR20140091458A (ko) | 2010-09-01 | 2014-07-21 | 아레나 파마슈티칼스, 인크. | 신장 손상을 갖는 개체에 대한 로카세린의 투여 |
| JP2013536859A (ja) | 2010-09-01 | 2013-09-26 | アリーナ ファーマシューティカルズ， インコーポレイテッド | ５−ｈｔ２ｃアゴニストの非吸湿性塩 |
| EP3485878A1 (en) | 2010-09-01 | 2019-05-22 | Arena Pharmaceuticals, Inc. | Modified-release dosage forms of 5-ht2c agonists useful for weight management |
| KR20130138770A (ko) | 2010-09-01 | 2013-12-19 | 아레나 파마슈티칼스, 인크. | 광학적으로 활성 산을 갖는 로르카세린의 염 |
| WO2014058441A1 (en) | 2012-10-09 | 2014-04-17 | Arena Pharmaceuticals, Inc. | Method of weight management |
-
1975
- 1975-10-01 SE SE7510988A patent/SE7510988L/xx unknown
-
1976
- 1976-09-07 ZA ZA765331A patent/ZA765331B/xx unknown
- 1976-09-11 DE DE19762640972 patent/DE2640972A1/de not_active Withdrawn
- 1976-09-15 AT AT682376A patent/AT347427B/de not_active IP Right Cessation
- 1976-09-16 FI FI762660A patent/FI762660A7/fi not_active Application Discontinuation
- 1976-09-22 SU SU762402852A patent/SU638252A3/ru active
- 1976-09-27 NZ NZ182165A patent/NZ182165A/xx unknown
- 1976-09-27 AU AU18122/76A patent/AU503212B2/en not_active Expired
- 1976-09-28 DD DD195022A patent/DD126278A5/xx unknown
- 1976-09-30 NO NO763345A patent/NO763345L/no unknown
- 1976-09-30 GB GB7640684A patent/GB1542317A/en not_active Expired
- 1976-09-30 ES ES451979A patent/ES451979A1/es not_active Expired
- 1976-09-30 NL NL7610845A patent/NL7610845A/xx not_active Application Discontinuation
- 1976-09-30 LU LU75916A patent/LU75916A1/xx unknown
- 1976-09-30 FR FR7629467A patent/FR2326183A1/fr not_active Withdrawn
- 1976-09-30 DK DK439776AA patent/DK141622B/da unknown
- 1976-10-01 JP JP51118924A patent/JPS5242840A/ja active Pending
- 1976-10-01 CS CS782253A patent/CS199644B2/cs unknown
- 1976-10-01 BE BE171148A patent/BE846837A/xx unknown
- 1976-10-01 CS CS766357A patent/CS199643B2/cs unknown
-
1977
- 1977-10-13 SU SU772532454A patent/SU674669A3/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| CS199644B2 (en) | 1980-07-31 |
| FI762660A7 (https=) | 1977-04-02 |
| SU674669A3 (ru) | 1979-07-15 |
| SU638252A3 (ru) | 1978-12-15 |
| LU75916A1 (https=) | 1978-05-16 |
| ATA682376A (de) | 1978-05-15 |
| GB1542317A (en) | 1979-03-14 |
| ES451979A1 (es) | 1978-01-01 |
| AT347427B (de) | 1978-12-27 |
| ZA765331B (en) | 1977-08-31 |
| NZ182165A (en) | 1978-07-10 |
| DK439776A (https=) | 1977-04-02 |
| FR2326183A1 (fr) | 1977-04-29 |
| DK141622B (da) | 1980-05-12 |
| BE846837A (fr) | 1977-04-01 |
| DE2640972A1 (de) | 1977-04-14 |
| SE7510988L (sv) | 1977-04-02 |
| NO763345L (https=) | 1977-04-04 |
| NL7610845A (nl) | 1977-04-05 |
| CS199643B2 (en) | 1980-07-31 |
| JPS5242840A (en) | 1977-04-04 |
| DD126278A5 (https=) | 1977-07-06 |
| AU1812276A (en) | 1978-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU536499B2 (en) | Glycinamide | |
| JPS55124497A (en) | Optionally hydrogenated starch hydrolysate * production and use thereof | |
| AU514849B2 (en) | Composition and process | |
| AU2632577A (en) | An improved product and process | |
| AU542701B2 (en) | 2 acylaminomethyl-1,4-benzodiazepines and salts | |
| AU503934B2 (en) | Amino chomanols | |
| AU503212B2 (en) | 1-(3,5-dihydroxyphenyl)-2[hydroxyalkyl)amino] ethanols and their esters | |
| AU518432B2 (en) | 3,4,5-trisubstituted-oxazolid and thiazolid-2-ones | |
| AU2844177A (en) | Azabicyclohexanes, methods of use and preparation | |
| AU535400B2 (en) | Wirebroadcast and viewphone | |
| AU521533B2 (en) | 1, 2-benzisoxazolozyacetic acids and related compounds | |
| AU503657B2 (en) | 4 amino ketone s | |
| AU507801B2 (en) | Olefinpoylmerization and Catalyst | |
| AU3465578A (en) | Preparation of 4-hydroxy-5-alkyl and 2, 5-dialkyl-3-oxo-2h-furans | |
| AU518375B2 (en) | Ester of mm4550, mm13902 and mm17880 | |
| AU513363B2 (en) | Dispencing method and article | |
| AU1828776A (en) | 1, 3-BENZODITHIOLE-2-ONE (and 2-THIONIC) DERIVATIVES | |
| AU499841B2 (en) | 3, 5-bisoxygenated 2(w-halo-3-oxygenated -1-alkenyl)-cyclopentane-1-heptanoic acids and derivatives thereof | |
| AU514888B2 (en) | Mono-insulin and method for preparation thereof | |
| AU512767B2 (en) | 2,9-dioxatricyclo [4,3,1,03,7] decans and the preparation thereof | |
| AU5635180A (en) | 3:,4:-diepi-4:-0-methyl-daunorubicin and derivatives | |
| AU549876B2 (en) | Dihydrocyclosporin d and isocyclosporin d | |
| AU482216B2 (en) | Composition and process | |
| AU489523B1 (en) | Pressurized bleeding method and means | |
| AU484869B2 (en) | 2, 5-di-substituted 4-oxazolealkanoic acids and esters |